CBIOS impact innovation strategy
Atualizado: 5 de mar.
Positive Benefits in partnership with Territórios Criativos implemented an impact innovation strategy to CBIOS, one of the biggest and higher impact research private center in Portugal.
CBIOS, the Research Center for Biosciences & Health Technologies was created in 2011 as a R&D structure of COFAC / Universidade Lusófona to create and promote knowledge in the health sciences. As part of our vision, CBIOS develops Integrated Health Strategies aimed to support the progress of Lusophone societies.
Knowledge creation is the main driver of development around the world. Dramatic changes in quality of life, life expectancy and well-being are direct results of this universally recognized progress. However, many asymmetries still persist, delaying the incorporation of these benefits in many societies. With regard to the progression of knowledge related to human health and social progress, CBIOS has a unique vision resulting from being part of the Lusófona Group, a dynamic institution of education, culture and knowledge present in most Portuguese-speaking countries.
MAIN METHODOLOGIES, OBJECTIVES AND OUTPUTS
Positive Benefits impact innovation strategy start to focus on the main objectives and scope of the intervention plan so that all expectations could be undertake. All steering definition of people to be involved in the entire process of engagement and the creation of detailed plan agreement.
Internal innovation collection of knowledge is a critical step. Most of the time, with the day be day work the history of CBIOS impact research activities services and products not integrated and connected in between all departments. Internal innovation comes from this time, of work with the installed capacity that needs to be nurtured and stimulated. When combined with global innovation best practices in this CBIOS research areas it can leverage new motivation and more focus in order to create an impactful strategy. The benchmarking is important to understand new or improved management models from the main national and/or international players, with similar performances.
The main objective was to determine the new/improved strategic dimensions with the adaptation of the diversification of the business model and team competencies. Also, the defining the baselines for the creation KPIs and an Action Plan (QW and medium term). Other objectives were implemented with the fine-tuning of the brand and communication materials in order to create a new presentation and institutional video of CBIOS.
Being an university-based unit, CBIOS is highly committed to Diversity, Equity and Inclusion. It is also privileged to operate within a broad-minded, multidisciplinary environment essential to foster innovation, promote advanced learning, and attract dynamic young researchers from different backgrounds and cultures.
CBIOS currently includes 19 integrated members, 25 PhD students, 27 collaborators, and a wide collaborative network, operating in four research domains – Natural Bioactives, Development of Delivery Systems, Pharmacology and Molecular Mechanisms, Modeling Systems, and Nutrition and Health Promotion.
Some of the main impact news from CBIOS in the last months:
Universidade Lusófona stands out for the first time in the Times Higher Education World University Rankings 2023, mainly due to the contribution of the Health Sciences area, where CBIOS and ECTS highly contributed;
Patricia Rijo appears on the “World's Top 2% Scientists list“, ranking made available by Stanford University, Califórnia, EUA;
CBIOS researcher win the EGON STAHL AWARD 2022 - The Egon-Stahl-Award is a scientific honour of the Society for Medicinal Plant and Natural Product Research (GA). In 2022, it was attributed to Epole Ntungwe for her outstanding contributions to the search for lead structures from Plectranthus species to combat multi-drug resistance in cancer;
CBIOS awarded at the NATIONAL CONGRESS OF SENOLOGY, with the work of Paulo Luz was distinguished at the XI National Congress of Senology, with the prize in the category of Medical Oncology - Early Disease;
CBIOS held the INNOVDELIVERY’22 that brought together 40 researchers from Europe, South America, and Asia to discuss the theme “Nature as inspiration for innovation in Health and Well-being”;
CBIOS promoted the 1ST AFRICAN CONFERENCE ON NATURAL PRODUCT AND RELATED FIELDS - The University of Technology, Cape Town, South Africa and CBIOS hosted the 1st International African Natural Products Congress. This event brought together around 60 researchers and updated research on the global natural products and their applications in areas such as food, medicine, and cosmetics.
Positive Benefits is committed to incorporate this powerful tool in every project we work on, identifying which of the 17 goals can the project relate to and creating specific solutions to achieve them.
The Sustainable Development Goals (SDGs), also known as the Global Goals, were adopted by the United Nations in 2015 as a universal call to action to end poverty, protect the planet, and ensure that by 2030 all people enjoy peace and prosperity.